2-111772465-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_022662.4(ANAPC1):c.5595T>A(p.Asp1865Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022662.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC1 | NM_022662.4 | c.5595T>A | p.Asp1865Glu | missense_variant | 47/48 | ENST00000341068.8 | NP_073153.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC1 | ENST00000341068.8 | c.5595T>A | p.Asp1865Glu | missense_variant | 47/48 | 1 | NM_022662.4 | ENSP00000339109.3 | ||
ANAPC1 | ENST00000427997.5 | c.4197T>A | p.Asp1399Glu | missense_variant | 36/37 | 1 | ENSP00000396695.1 | |||
ANAPC1 | ENST00000462785.1 | n.2289T>A | non_coding_transcript_exon_variant | 3/4 | 2 | |||||
ANAPC1 | ENST00000643447.1 | n.621T>A | non_coding_transcript_exon_variant | 7/12 | ENSP00000494863.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 18
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | The c.5595T>A (p.D1865E) alteration is located in exon 47 (coding exon 46) of the ANAPC1 gene. This alteration results from a T to A substitution at nucleotide position 5595, causing the aspartic acid (D) at amino acid position 1865 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.